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Since the first reported case of AIDS 27 
years ago, more than 70 million people have 
been infected with HIV worldwide, and 25 
million have died of AIDS. The Joint United 
Nations Programme on HIV/AIDS (UNAIDS) 
estimates that 33 million people are cur-
rently living with HIV. The global prevalence 
of HIV has leveled off, but the total number 
of people living with HIV continues to grow.1
This article briefly discusses the roles 
that different HIV transmission modes play 
in the worldwide pandemic, and explains 
how the global pandemic is actually a com-
plex mosaic of dynamic epidemics within 
and between countries.2 Further, it dis-
cusses matching appropriate prevention 
responses to two different types of epi-
demics: generalized and concentrated.
Modes of Transmission
HIV continues to spread relentlessly. Sex-
ual transmission, both among heterosexuals 
and men who have sex with men, accounts 
for about 84 percent of all infections globally. 
In settings where heterosexual transmission 
is dominant, there is also an HIV epidemic in 
infants born to HIV-positive mothers. About 
6 percent of all infections globally are asso-
ciated with this “vertical” transmission. HIV 
antiviral treatments, together with formula 
feeding, have virtually eliminated vertical 
transmission in industrialized countries, but 
in some areas where HIV antiviral treatments 
are not available, or pregnancy and birth are 
largely unsupervised, or where water sup-
plies are not safe to use for formula feeding, 
vertical transmission continues. 
Approximately 5 percent to 7 percent of 
infections worldwide are associated with 
injection drug use, but in some areas of Cen-
tral Asia and Eastern Europe, it accounts for 
at least two-thirds of new infections. Con-
versely, extensive screening of blood and 
blood products, which occurs routinely in 
resource-rich areas, has eliminated transmis-
sion via blood transfusion and hemophilia 
treatment in most, but not all, settings.
A Complex Mosaic
The HIV pandemic (that is, the global dis-
tribution of HIV infection) is actually com-
posed of a network of local and regional 
epidemics. An epidemic is the emergence 
and rapid spread of a disease in a certain 
area or among a certain population group 
that were previously free of infection. In 
contrast, a disease is endemic if it is con-
stantly present in a certain geographic area. 
Local and regional HIV epidemics are 
diverse. One way to understand the differ-
ences among these epidemics is to consider 
what “stage” of the epidemic a region is expe-
riencing. UNAIDS offers one classification 
system that describes generalized epidemics 
as ones in which HIV is widely established 
throughout the population, and the virus is 
spread primarily through heterosexual sex. 
Concentrated epidemics are those in which 
HIV is primarily restricted to defined popula-
tions, such as men who have sex with men, 
commercial sex workers, or injection drug 
users. As will be discussed below, the impli-
cations for prevention responses are differ-
ent for these two types of epidemics.
A Generalized Epidemic
Although only about one-tenth of the 
world’s population resides in sub-Saharan 
Africa, two-thirds of all the HIV-positive 
people in the world—22 million people—
live here. In 2007, there were 1.9 million new 
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infections.1 Because of the high prevalence 
(greater than 5 percent of the adult popula-
tion) and because heterosexual transmission 
is dominant, sub-Saharan Africa is a clas-
sic example of a generalized epidemic. Even 
more stark, HIV prevalence in seven South-
ern African countries—Botswana, Lesotho, 
Namibia, South Africa, Swaziland, Zambia, 
and Zimbabwe—is considered hyperendemic. 
That is, prevalence rates exceed 15 percent, 
with new infection rates higher than 5 per-
cent per year and rapidly increasing illness 
and death rates. South Africa, with an esti-
mated 5.7 million residents living with HIV, 
has the largest HIV epidemic in the world.1
There has been a slow recognition of 
the importance of customizing prevention 
responses to local epidemic characteristics.  
Effective interventions with vulnerable popu-
lations can contain the spread of disease in a 
concentrated epidemic. In contrast, a general-
ized epidemic requires multiple, widespread 
interventions. In certain generalized epidem-
ics, some researchers have identified two 
key drivers of infection: concurrent sexual 
 partnerships and lack of circumcision among 
men.3 Thus, promoting the social norm of 
monogamous partnerships and making cir-
cumcision more safe and affordable may be 
key steps to confronting this epidemic.3
One catalyst for partner concurrency (in 
which an individual goes back and forth 
between sexual partners, greatly increas-
ing the risk of acquiring and transmitting 
HIV) in this region has been the migrant 
labor system, which has removed young 
men from rural settings for as long as 11 
months each year. As a consequence, mar-
riage has become rare, and sexual part-
nerships are more transient and more 
concurrent. But the migrant labor sys-
tem also drives risk in another way. Mar-
riage typically confers economic protection 
on women, and many women who remain 
unmarried are ultimately drawn into sex 
work to survive. Thus, understanding how 
to intervene in this economic context is one 
of the many challenges facing prevention 
professionals in this generalized epidemic. 
The only biomedical advance to prevent 
The Centers for Disease Con-
trol and Prevention (CDC) released 
its new HIV incidence estimates in 
August 2008 to a mix of interest, 
controversy, and criticism. Much of 
the harsher commentary stemmed 
from delays in releasing the informa-
tion—the CDC elected to go through 
a peer review process to ensure the 
accuracy of the numbers—and the 
fact that the number of new infec-
tions annually was 40 percent higher 
than had been previously believed. 
Some critics even charged that these 
new, much higher estimates meant 
that “prevention had failed.”
 It is demoralizing to realize that 
the U.S. epidemic is even larger than 
we thought. Yet the articles in this 
issue of FOCUS suggest that it is not 
that HIV prevention has failed, but 
that prevention resources need to 
be more appropriately targeted in 
order to reduce HIV infection rates. 
In their article, Quarraisha 
Abdool Karim and Leya Hassan-
ally explain how “generalized” and 
“concentrated” HIV epidemics dif-
fer, and why considering these dif-
ferences is important for success-
ful prevention efforts. They note 
that in generalized epidemics, 
such as South Africa’s, HIV preva-
lence is devastatingly high, and 
heterosexual and mother-to-child 
transmission are common. In con-
trast, in countries with concen-
trated HIV epidemics, such as the 
United States, stigma often stands 
in the way of appropriate preven-
tion responses. Since those most at 
risk in a concentrated HIV epidemic 
tend to be from marginalized popu-
lations, their identities and behav-
iors may be hidden, thwarting the 
possibility of prevention. 
Patrick Sullivan, Amy Zapata, 
and Nanette Benbow, in the second 
 article, go behind the CDC incidence 
estimates. They point out that while 
these new numbers give a more 
accurate account of the scope of the 
epidemic, they do not fundamentally 
contradict what we already know 
about who is becoming infected in 
the United States: men of all races 
who have sex with men, and African 
Americans and Latinos of both sexes. 
The take-home message I got 
from this article is that these more 
precise numbers give us another 
chance to recommit ourselves to tar-
geting prevention resources appro-
priately, an especially important 
insight during a time of fresh starts 
and tight budgets. While anyone can 
get HIV, the truth is that some of us 
are much more likely to be at risk 
than others. Of course, it is harder 
to maintain public interest in HIV 
prevention as a national priority if 
large segments of our population 
feel immune. That may be the ulti-
mate prevention challenge: general-
izing public concern about HIV while 
concentrating efforts in the commu-
nities that need them most. n
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sexual HIV transmission in three decades 
is circumcision. Recent randomized con-
trolled trials demonstrate a 50 percent to 
60 percent protective effect for the cir-
cumcised man who has sex with women.4 
In a generalized HIV epidemic where pre-
existing circumcision rates are low and HIV 
prevalence and incidence rates are high, 
promoting and providing safe and afford-
able circumcision services to men is critical 
to reducing transmission.3
“Generalized” prevention strategies that 
more directly benefit women are urgently 
needed. Women account for 57 percent of 
HIV cases in sub-Saharan Africa, and three-
quarters of the young people living with 
HIV on the continent of Africa are women 
aged 15 to 24 years old.5 Despite the dra-
matic impact of HIV 
disease on women in 
the region, most pre-
vention and treat-
ment efforts related 
to women have been 
directed at preventing 
maternal-child trans-
mission, an effort that 
has been quite suc-
cessful but has not 
addressed the press-
ing need for HIV pre-
vention and treat-
ment in women. 
Some biomedical interventions that 
could help stem the tide of HIV infection 
in both women and men, including dia-
phragms, acyclovir treatment of herpes 
simplex virus 2, and several microbicide 
products and vaccines, have been tested 
but have not yet proven effective. Research-
ers are currently testing the HIV antiviral 
drug tenofovir to determine its HIV preven-
tion effectiveness in both sexes.
Access to HIV antiviral drugs in 
resource-constrained settings has dramat-
ically increased, especially in these sub-
Saharan regions of Africa. This increased 
access may also reduce transmission by 
reducing viral load levels in HIV-positive 
people, yet many who need them still lack 
these drugs. Failing health care delivery 
systems, stigma, discrimination, and lim-
ited human resource capacity are among 
the systemic and social obstacles that must 
be confronted for a truly effective response 
to this generalized epidemic. 
A further challenge in this region is the 
concurrent, large tuberculosis epidemic 
among HIV-positive people. Until recently, 
it was unclear whether or not an HIV-pos-
itive person should initiate HIV antiviral 
treatment prior to the completion of anti-
tuberculosis treatment, so HIV antiviral 
treatment was often delayed. A new clini-
cal trial suggests that giving HIV antiviral 
treatment during anti-tuberculosis treat-
ment could reduce mortality rates in this 
population by 55 percent.6
Concentrated Epidemics
The prevention challenge in a concentrated 
epidemic stems from the fact that those 
infected are usually from groups whose 
behaviors are stigmatized, and sometimes 
outlawed: injection drug use, sex between 
men, and commer-
cial sex work. While 
effective prevention 
with these vulnera-
ble populations would 
be enough to reverse 
the growth of the epi-
demic, stigma often 
causes these popula-
tions to remain hidden 
and underserved. This 
makes even estimating 
the size of the vulnera-
ble populations, not to 
mention HIV preven-
tion, difficult. “Concentrated epidemic” tech-
niques include saturating vulnerable popu-
lations with high-quality, targeted interven-
tions, while engaging in stigma reduction 
campaigns for the general population.3 The 
United States and China offer two examples 
of areas with concentrated epidemics.
The United States. The HIV epidemic in 
the United States, like the epidemic in Can-
ada, Central and South America, Europe, 
and Australasia, is a concentrated one. 
There are approximately 1.2 million people 
living with HIV in the United States, and 
there is an HIV prevalence rate of 0.6 per-
cent, with an estimated 56,300 new infec-
tions occurring annually.7,8
In the United States, the key vulnerable 
populations are men who have sex with 
men (48 percent of those living with HIV), 
injection drug users (19 percent), men 
who both have sex with men and inject 
drugs (5 percent), and those engaged in 
“high-risk” heterosexual intercourse (28 
percent). “High-risk” heterosexual inter-
4. Gray RH, Kigozi 
G, Serwadda D, et 
al. Male circumci-
sion for HIV preven-
tion in men in Rakai, 
Uganda: A randomised 
trial. Lancet. 2007; 
369(9562): 657–666.
5. Joint United Nations 
Programme on HIV/
AIDS. Women, girls, 
gender, GCWA. 
Geneva, Switzer-
land: Joint United 
Nations Programme 





6. Centre for the AIDS 
Programme of Research 
in South Africa. Press 
Release—Important 
New Research Findings 
on Treatment of 
TB-HIV Co-infection. 
Durban, South Africa: 
CAPRISA—Centre for 
the AIDS Programme 






7. Centers for Disease 
Control and Prevention. 
CDC HIV/AIDS Facts: 
New Estimates of U.S. 
HIV Prevalence, 2006. 
Atlanta: Centers for 






8. Centers for Disease 
Control and Prevention. 
CDC HIV/AIDS Facts: 
Estimates of New HIV 
Infections in the United 
States. Atlanta: Centers 






There has been a slow 
recognition of the 
importance of customizing 
prevention responses 
to local epidemic 
characteristics.
4   FOCUS   Fall 2008
course is defined as “sex with a partner 
“known to have, or be at high risk for, HIV 
infection,” including sex with injection 
drug users.7 Prevention strategies suitable for 
concentrated epidemics—needle exchange, 
drug substitution programs (such as metha-
done maintenance), and other harm reduc-
tion measures—have led to a decline in the 
U.S. epidemic among injection drug users.9 
This is true despite the fact that it is illegal 
for federally funded programs to offer needle 
exchange services.
Likewise, the emphasis on maternal HIV 
testing and prophylactic HIV antiviral treat-
ment has nearly eradicated vertical trans-
mission in the United States. While this is a 
great success story, it has not had a tremen-
dous impact on the number of total infec-
tions in the United States, because mother-
to-child transmission is not a critical driver 
of new infections in the U.S. epidemic as it 
is in areas of generalized HIV rates. 
The U.S. epidemic continues to grow 
among key subpopulations, particularly 
young Black men who have sex with men 
and Black heterosexual women. In fact, 
the epidemic is concentrated in the United 
States not only by transmission category, 
but also by race. Black people make up only 
12 percent of the U.S. population, yet they 
accounted for 46 percent of HIV cases in 
2006. HIV also disproportionately affects 
Latinos—the HIV prevalence rate among Lati-
nos is 2.6 times that of Whites.7 Following 
a “concentrated” epidemic prevention strat-
egy means directing additional behavioral 
intervention resources to these hardest hit 
groups: men who have sex with men, and the 
Black and Latino communities, with special 
emphasis on Black and Latino men who have 
sex with men and Black and Latina women.
China. The overall HIV prevalence in 
Asia remains low. Yet, because of the con-
tinent’s enormous population, the abso-
lute numbers of people living with HIV 
are high, especially in India and China. In 
China, prevalence across the entire popu-
lation is estimated at .05 percent, but, as 
home to one-fifth of the world’s population, 
this means that 700,000 people were living 
with HIV there in 2007.10 UNAIDS estimates 
that, among people living with HIV in China 
in 2007, 40.6 percent were infected through 
heterosexual transmission, 11 percent 
through sex between men, 38.1 percent 
through shared injection equipment, and 
9.3 percent through contaminated blood 
products. Maternal-child transmission was 
responsible for just 1 percent of cases.10
Commercial sex work plays an impor-
tant role in bridging between communities 
in which the epidemic is more concentrated 
and less concentrated. Women who inject 
drugs often sell sex to survive and to pay 
for drugs. Men who inject drugs are more 
likely to purchase sex than are men who do 
not inject drugs.11
In response to the epidemic among injec-
tion drug users, the Chinese government ini-
tially focused on educating substance users 
on the harms of drug use, but in the late 
1990s, its attitude changed and a pilot nee-
dle exchange program began in 2000. Today, 
both needle exchange and drug substitution 
programs (such as methadone maintenance) 
exist: there are 729 needle exchange stations 
in China, and two-thirds of provinces have 
methadone maintenance clinics.10,11 Simi-
larly, the Chinese government was initially 
reluctant to take prevention measures with 
sex workers, fearing such measures would 
encourage prostitution. Prevention now var-
ies by province, with some regions intro-
ducing the “100 percent condom use” policy, 
similar to Thailand’s successful campaign to 
reduce new infections by mandating condom 
use in brothels.11
Homosexuality in China is stigmatized, the 
consequences being that most men who have 
sex with men are married and it is difficult 
to openly discuss HIV risk reduction mea-
sures. Earlier this year, however, the Minis-
try of Health announced that it would target 
resources toward this vulnerable population 
with specific HIV prevention programs.11
Conclusion
Sub-Saharan Africa, the United States, and 
China offer three examples of the worldwide 
diversity of the HIV pandemic. Epidemic 
typology—the classification of these epi-
demics—offers one way to think about the 
nature and challenges of generalized and 
concentrated epidemics, to plan prevention 
responses, and to allocate resources. 
While these typologies suggest divergent 
interventions, it is important to remember 
that even within generalized epidemics, 
there are vulnerable populations whose 
specific needs must be considered. Like-
wise, in concentrated epidemics, large-
scale social change may be necessary to 
reduce the marginalization associated with 
stigmatized identities. n 
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In August 2008, the Centers for Dis-
ease Control and Prevention (CDC) signifi-
cantly revised its estimates of the annual 
number of new HIV infections in the United 
States. While the previous incidence esti-
mate had been about 40,000 new infec-
tions annually, the August 2008 report 
suggests that the true number is closer 
to 56,300 new infections per year. 
This article reviews the new HIV incidence 
estimates and offers some context as to how 
the CDC derived them. It also explores how 
the new incidence data compare to previ-
ously available data from HIV/AIDS case sur-
veillance systems, and where the incidence 
data suggest prevention efforts be focused. 
A New Way of Counting
To understand the significance of the new 
incidence numbers, it is important to under-
stand how they and previous estimates of 
incidence were derived. Historically, HIV 
incidence in the United States has been esti-
mated using informal approaches based on 
incidence in specific risk subpopulations, 
and through back-calculation approaches. 
In back-calculation studies, epidemiologists 
noted the number of AIDS cases that were 
reported in a given period of time. They 
then estimated when each of these people 
with AIDS was likely to have been infected 
with HIV. These estimates of when infec-
tion occurred were based on assumptions of 
a predictable period of time between infec-
tion and AIDS diagnosis. With the advent of 
effective HIV antiviral treatments, the length 
of time between HIV infection and diagno-
sis with AIDS became both longer and more 
variable, so this method became unreli-
able.1,2 Also, after HIV infection became a 
reportable condition, there was more infor-
mation about the number of people with 
HIV who had not progressed to AIDS. 
More recently, the CDC began using a 
newly developed blood testing method: 
the BED HIV-1 capture enzyme immuno-
assay (or “BED”).3 This test can distinguish 
people whose HIV infections were likely 
acquired within the prior six months from 
those whose infections are of longer dura-
tion. This technology has allowed the CDC 
to expand its routine HIV/AIDS case surveil-
lance system (which includes all reported 
HIV and AIDS diagnoses for a year) to cre-
ate a new incidence surveillance system 
that can estimate specifically the num-
ber of newly acquired HIV infections. This 
much more accurate incidence estimate 
will give epidemiologists a true snapshot of 
how and where the epidemic is growing. 
To estimate these HIV incidence rates, 
serum remaining from HIV antibody tests 
is sent to a reference laboratory for test-
ing with the BED immunoassay. The results 
from the BED testing are used in conjunc-
tion with information collected as part of 
case reporting to determine how many of 
these newly diagnosed individuals are also 
newly infected. For the 2006 national esti-
mate, samples analyzed came from 22 
states. Because these 22 states represent 
more than 70 percent of the total num-
ber of U.S. AIDS cases, these data are con-
sidered to reflect HIV incidence in the 
nation as a whole. For this incidence esti-
mate, however, serum samples from only a 
small percentage (17 percent of newly diag-
nosed people) were tested using BED.3 
Researchers determined that approxi-
mately 31 percent (2,133 people) of the 
cases tested using the BED assay represented 
recent infections.3 They then used their 
understanding of the demographics and test-
ing history of this group of newly infected 
people, as well as information from those 
whose specimens were not tested, to “multi-
ply up” to their estimates of HIV incidence in 
the entire U.S. population. This new method 
of estimating HIV incidence is known as 
a “stratified extrapolation approach.”
Although the new data show that the epi-
demic is worse than was previously known, 
the main difference between the previous 
CDC estimate of 40,000 new infections per 
year and the new HIV incidence estimate is 
that the new estimate is a much more accu-
rate reflection of what the true incidence of 
HIV has been in the United States for some 
time. While the new numbers do mean that 
more people per year were becoming infected 
than was previously believed, they do not 
mean that there has been a recent “jump” 
in new infections—only an improvement in 
our ability to recognize new infections. 
The primary value of the new incidence 
estimate method is that it will now be eas-
ier to identify shifts in the course of the 
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epidemic and trends over time sooner. For 
example, increases in new HIV diagnoses 
among men who have sex with men began as 
early as 1999, but it was not until 2008 that 
epidemiologists made a definitive statement 
noting increasing HIV incidence trends in 
this population.4 Examining year-to-year esti-
mates of HIV transmission will allow pub-
lic health scientists to recognize these new 
trends earlier, and make changes in funding 
and programmatic priorities more quickly. 
What the New Numbers Mean
The new incidence numbers generally con-
firm what existing case surveillance data had 
previously shown about the impact of the U.S. 
epidemic on men who have sex with men and 
Black Americans. Although the news of the 
revised estimate has generated much excite-
ment, the new estimates offer few surprises: 
the new data do not suggest that the current 
state of the epidemic or recent trends in the 
epidemic in the United States are substantially 
different from what was previously believed. 
Rather, they remind us of the important roles 
of race, age, gender, and routes of transmis-
sion in understanding the current epidemic. 
Incidence data suggest that, in 2006, more 
than half of new HIV infections occurred 
among men who have sex with men.3 Fur-
ther, men who have sex with men were the 
only transmission category for which HIV 
incidence increased since the year 2000. But 
these findings are not new: they echo pre-
vious findings from case surveillance data. 
Case surveillance data indicate that, in 2006, 
50 percent of new HIV case reports were from 
men who have sex with men, and trend analy-
sis of HIV case report data indicated increas-
ing trends in HIV infection among men who 
have sex with men from 2001 to 2006.4 
Among men who have sex with men, 
the patterns of new HIV infections varied 
among racial and ethnic groups: more newly 
infected men of color were in younger age 
groups, compared with newly infected White 
men. The largest group of new HIV infec-
tions among Black and Hispanic men who 
have sex with men were among men aged 
13 to 29, whereas the largest group of new 
infections in White men who have sex with 
men were among men aged 30 to 39.5 
Forty-five percent of new infections in 
2006 occurred among Blacks.5 Heterosexual 
transmission accounted for 83 percent of 
new infections among Black women, but only 
20 percent of new infections among Black 
men.5 Black women accounted for 61 per-
cent of new infections in women, and inci-
dence rates in Black women were 14.7 times 
as high as those of White women. Black 
men accounted for 40 percent of new infec-
tions among men, and had incidence rates 
5.9 times as high as those of White men.
In contrast, only approximately 12 per-
cent of new infections in 2006 occurred 
among injection drug users. From a 
high in 1998–2000, new HIV infections 
among injection drug users declined 
80 percent through 2003–2006.6
Thus, the new 2006 incidence estimates 
and trends largely reinforce the relevance 
of the CDC’s recently established HIV pre-
vention priorities. For example, in 2007 
the CDC announced a Heightened National 
Response to the African American HIV epi-
demic in the United States, and has since 
taken important steps to engage commu-
nity, religious, and scientific leaders in this 
response.7 According to the CDC’s Com-
pendium of Effective HIV Prevention Inter-
ventions, 20 of the 31 (65 percent) “best 
evidence” interventions have been tested 
with a majority Black study population.
Conversely, while public health scientists 
and local community planning groups have 
long recognized that men who have sex with 
men represent the largest (and, according 
to new data, still growing) HIV subepidemic 
in the United States,4 prevention interven-
tions for use with this group remain inad-
equate. Although men who have sex with 
men bore the burden of more than half of 
the new HIV infections in 2006, only four 
(13 percent) of the 31 “best evidence” HIV 
prevention interventions have been tested 
among men who have sex with men, and 
none of those four interventions has been 
tested in a study population with a major-
ity of Black men who have sex with men.8
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ers to submit article proposals. Send cor-
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Editor, FOCUS, UCSF AIDS Health Project, 
Box 0884, San Francisco, CA 94143-0884.
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Looking to the Future
The new incidence numbers underscore 
the need for the strategic allocation of 
research and prevention resources. In partic-
ular, additional resources must be devoted 
to the development and dissemination of 
new HIV prevention interventions for men 
who have sex with men, especially men of 
color who have sex with men. The drivers 
of risk may be different for these men than 
they are for either Black and Hispanic men 
who have sex only with women or White 
men who have sex with men. With the high 
annual number 
of new HIV infec-
tions among young 
men who have sex 
with men, there is a 
need to ensure that 
prevention efforts 
reach each new gen-
eration. In addition, 
there are still major 
gaps in our under-
standing of the role 
of stigma, poverty, 
and incarceration as 




tor Julie Gerberding 
recently noted, dra-
matically increased 
resources are needed at all levels of the 
U.S. HIV prevention system.9 An analysis 
of funds available to support HIV preven-
tion efforts shows a 19 percent reduction 
in CDC’s inflation-adjusted prevention bud-
get since fiscal year 2002.10 The new inci-
dence numbers confirm the existence of a 
reemerging epidemic among men who have 
sex with men and ongoing, stark dispari-
ties by race and ethnicity. With the excite-
ment of this new, clearer view of the U.S. 
HIV epidemic comes the responsibility to 
respond by committing new resources to 
these high-priority populations, and to use 
existing resources to prevent new infec-
tions among those suffering the greatest 
impact of HIV infection in the United States. 
Translating the benefit of this new infor-
mation to affected communities is more 
than a federal effort. The community plan-
ning process makes local prevention efforts 
more responsive to local epidemics. If local 
incidence and case surveillance data sug-
gest increasing trends in men who have sex 
with men or in communities of color simi-
lar to national trends, the new data should 
prompt reevaluation of local prevention 
portfolios to ensure alignment of allocation 
of prevention with current trends. Track-
ing new infections over time will comple-
ment data from HIV case surveillance to 
help evaluate and inform local preven-
tion efforts and ensure responsible pri-
oritization of limited prevention funds.
Another key to deriving the greatest ben-
efit from this new system is more compre-
hensive testing of serum 
specimens. 2006 is the 
first year for which epi-
demiologists have based 
HIV incidence estimates 
on information from blood 
specimens together with 
case surveillance data. 
The CDC incidence sur-
veillance system obtained 
blood specimens from 
only 17 percent of people 
newly diagnosed with HIV 
in 2006. To reduce the risk 
of bias in the surveillance 
system, a higher percent-
age of specimens should 
be tested; some federal 
agencies suggest mini-
mum completion rates of 
40 percent to 80 percent 
for data systems that have a high impact 
on policy decisions.11,12 Although surveil-
lance systems are different from other kinds 
of surveys, efforts are needed to improve 
the completeness of specimen acquisition 
and to discover whether the small percent-
age of specimens obtained by the system 
affects the conclusions about HIV incidence.
Conclusion
While the new U.S. HIV incidence numbers 
do not reveal an epidemic that is qualita-
tively different from what was previously 
understood, they do confirm stark dispari-
ties about who is becoming infected—and 
an understanding of these disparities must 
drive research and prevention efforts. The 
American public has made a substantial 
investment in a new data system that is a 
leap forward in the science of surveillance; 
we owe it to those at greatest risk for HIV to 
insist that research and prevention resources 
be prioritized according to its findings. n
12. Public Works and 
Government Services 
Canada. Standards and 
guidelines for: Response 
rate. Advisory Panel 
on Telephone Public 
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The new incidence 
numbers confirm 
the existence of a 
reemerging epidemic 
among men who 
have sex with men, 
and ongoing, stark 
disparities by race and 
ethnicity.
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Journal Articles
Baral S, Sifakis F, Cleghorn F, et al. Ele-
vated risk for HIV infection among men 
who have sex with men in low- and mid-
dle-income countries 2000–2006: A sys-
tematic review. PLoS Medicine. 2007; 
4(12): e339. Reviews 83 HIV studies of men 
who have sex with men including 38 low-and 
middle-income countries in Asia, Africa, the 
Americas, and Eastern Europe. Meta-anal-
ysis revealed that men who have sex with 
men had 19.3 times the chance of being HIV-
positive as did the general population of 
reproductive-age adults. The authors call for 
greater inclusion of men who have sex with 
men in prevention programs and expansion 
of surveillance efforts to include men who 
have sex with men in countries where they 
are currently ignored. 
Mathers CD, Loncar D. Projections of 
global mortality and burden of dis-
ease from 2002 to 2030. PLoS Medicine. 
2006; 3(11): e442. Charges that previous 
estimates of global mortality and disease 
burden substantially underestimated the 
spread of HIV and AIDS. Attempts to sup-
port international health policy priority set-
ting by offering new global projections for 
a variety of diseases, including HIV disease. 
Offers a “baseline” scenario suggesting that 
annual worldwide AIDS deaths will rise from 
2.8 million in 2002 to 6.5 million by 2030 
even if HIV antiretroviral therapy treatment 
reaches an 80 percent coverage level across 
all regions by 2012. This scenario does not 
account for any reduction in HIV transmis-
sion as a result of treatment or enhanced 
prevention efforts. Much of the growth, both 
in HIV incidence and deaths in these projec-
tions, is due to the population growth that is 
projected in sub-Saharan Africa. 
Schwarcz S, Weinstock H, Louie B, et al. 
Characteristics of persons with recently 
acquired HIV infection: Application of 
the Serologic Testing Algorithm for 
Recent HIV Seroconversion in 10 U.S. Cit-
ies. Journal of Acquired Immune Defi-
ciency Syndromes. 2007; 44(1): 112–115. 
Explains how the Serologic Testing Algorithm 
for Recent HIV Seroconversion (STARHS) 
method was used to test the specimens of 
964 HIV-positive participants in 10 U.S. cit-
ies in order to determine the recency of their 
HIV infections. Reveals those who were more 
often infected within the last 170 days: men, 
men who have sex with men, people with 
a known HIV-positive partner, and people 
with a gonorrhea diagnosis in the past year 
—as well as those who had more often been 
infected more than 170 days: African Ameri-
cans, Latinos, heterosexual men, and women.
Web Sites
Kaiser Family Foundation: HIV/
AIDS: http://www.kff.org/hivaids/.
This organization publishes reports, 
fact sheets, and slide sets on both the 
global and domestic HIV situation. 2008 
fact sheets include updates on the HIV 
epidemics in Asia, South Africa, and sub-
Saharan Africa, and on the U.S. epidemic 
and Black Americans, Latinos, and women. 
World Health Organization (WHO): 
Health Topics—HIV/AIDS. http://www.
who.int/topics/hiv_aids/en/.This site offers 
a global online HIV database and epidemiologi-
cal fact sheets on HIV and sexually transmitted 
infections for 170 countries. Single-page coun-
try profiles include multi-year information on 
HIV prevalence, number of people living with 
HIV, annual number of deaths, and degree of 
HIV antiviral therapy coverage by country. n
Next Issue 
In the Winter 2009 issue of FOCUS, 
Christian Grov, PhD, MPH, MPhil, 
Assistant Professor in the Department 
of Health and Nutrition Sciences at the 
City University of New York, explores 
the complicated intersections between 
sexually compulsive behavior, the Inter-
net, and HIV risk and risk reduction.
Also in the Winter issue, John 
Giugliano, PhD, LCSW, Assistant 
Professor at the Center for Social 
Work Education at Widener Univer-
sity, delves into the clinical debate 
over the concept of sexual compul-
sivity itself, examining the features 
of out-of-control sexual behavior and 
explaining what HIV service provid-
ers need to know about its prevention 
and treatment.
Executive Editor; Director, 
AIDS Health Project 
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